Top Story

Small molecule inhibitor appears effective, safe for advanced head and neck cancer

Small molecule inhibitor appears effective, safe for advanced head and neck cancer
July 23, 2018
In the Journals Plus

‘Simply not acceptable’ to ignore financial toxicity of cancer treatment

July 23, 2018
A substantial proportion of patients with breast cancer did not feel clinicians adequately addressed their concerns about financial toxicity, study data showed…

Biosimilars Safe, Effective Alternatives to Originator Biologics

July 23, 2018
As the first biosimilars are being introduced and becoming more common in the United States, it is worthwhile to understand how the approval process works. With fewer…

Radiation oncologists join NYU Langone Health’s Perlmutter Cancer Center

July 22, 2018
Two nationally recognized radiation oncologists have joined the department of radiation oncology at NYU Langone Health’s Perlmutter Cancer Center. Andrew

AACR presents grant for transformative cancer research

July 21, 2018
The American Association for Cancer Research named Birgit Knoechel, MD, PhD, as the inaugural recipient of the AACR-The Mark Foundation NextGen Grant for Transformative…
More Headlines »

Ace the Case: A 72-Year-Old, Healthy, and Asymptomatic Woman With Incidentally Diagnosed Leukemia

There is no commercial support for this activity.

This educational activity will discuss the management of a 72-year old, asymptomatic female with severe leukopenia…
More »
Meeting News

VIDEO: Lenvatinib-pembrolizumab shows promise in several cancer types

June 22, 2018
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting


Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

The integration of immune checkpoint inhibitors into treatment algorithms for the management of advanced genitourinary…
More »
Current Issues
View the Current Issue
HemOnc Today